BioinformaticsbioRxivPreprint
Development and validation of an AI/ML platform for the discovery of splice-switching oligonucleotide targets
Alyssa D Fronk, Miguel Ángel Manzanares, Paulina Zheng…·Martin Akerman
This paper develops SpliceLearn, an AI/ML tool for identifying splice-switching oligonucleotide targets, and validates its effectiveness in predicting therapeutic targets in triple negative breast cancer.
DOI 10.1101/2022.10.14.512313